May 22, 2014 by Brad Perriello
Johnson & Johnson is planning to file for approval for 30 ‘major’ medical devices worldwide through 2016 and is working on its own surgical robot, executives from its medical device & diagnostics business told analysts today.
Click image to enlarge
Johnson & Johnson‘s (NYSE:JNJ) medical device & diagnostics division plans to file for approval for some 30 “major” products over the next 3 years from regulators, executives told analysts today at an investors meeting.
The pipeline includes planned filings for orthopedic, surgical and diabetes care devices in the U.S., Europe and Japan through 2016 – and an entry into the robot-assisted surgery arena, executives said at the meeting today in New Brunswick, N.J.
